Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OSTEOPORE LIMITED Director's Dealing 2023

Jul 6, 2023

65512_rns_2023-07-06_70d93f27-0c74-455d-9730-dcc91a28c466.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [145 x 59] intentionally omitted <==

ASX RELEASE | OSTEOPORE LIMITED

Rectification of Breach of ASX Listing Rule 10.11

7 July 2023: Osteopore Limited (ASX: OSX) (“ Osteopore ” or the “ Company ”) refers to the announcement dated 26 June 2023 titled ‘Notification of Breach of ASX Listing Rule 10.11’ and wishes to advise that the breach has now been rectified.

Mr Leong has disposed of the Top-Up Securities, being 162,500 Osteopore Shares and 162,500 Quoted Options, on market. The profit made on the transaction of $1,926.80 has been donated to The Magic Coat Foundation, a not-for-profit organisation focused on providing mental health programs to Western Australian children.

Capitalised terms used, but not defined in this announcement, have the meaning given to them in the Company’s prospectus released to ASX on 13 March 2023.

An Appendix 3Y recording Mr Leong’s change in interests will be published to ASX.

This announcement has been authorised for release by the Board of Osteopore.

Kellie Davis Joint Company Secretary

Osteopore Limited (ACN 630 538 957) ASX:OSX│ Level 5, 191 St. Georges Terrace, Perth WA 6000│ PO Box 7059, Cloisters Square PO, Perth WA 6850│+61 2 8072 1400│www.osteopore.com